Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04963556 |
Other study ID # |
2017-01079 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 18, 2017 |
Est. completion date |
April 15, 2018 |
Study information
Verified date |
July 2021 |
Source |
University of Basel |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Background:
The consumption of Energy Drinks (EDs) can acutely lead to negative side effects, such as
raised blood pressure and impaired endothelial function. Nevertheless, they are sold
worldwide and are often consumed before physical activity (PA). In contrast to the blood
pressure elevating effect of EDs, PA leads to a reduction of blood pressure. The effect of ED
consumption on blood pressure response during and after endurance training is currently
unresolved.
Methods:
A total of 23 participants (eleven men, twelve women) were evaluated in the intervention
study with a blinded Cross-Over Design. They consumed on two different days either 355 ml Red
Bull (RB) or 355 ml Placebo (Pla) in randomised order. The peripheral (PBP) and central blood
pressure (CBP) were measured before, during and after a 30-minute aerobic endurance training,
by the Schiller BR-102 plus PWA device.
Description:
Background:
The consumption of Energy Drinks (EDs) can acutely lead to negative side effects, such as
raised blood pressure and impaired endothelial function. Nevertheless, they are sold
worldwide and are often consumed before physical activity (PA). In contrast to the blood
pressure elevating effect of EDs, PA leads to a reduction of blood pressure. The effect of ED
consumption on blood pressure response during and after endurance training is currently
unresolved.
Methods:
A total of 23 participants (eleven men, twelve women) were evaluated in the intervention
study with a blinded Cross-Over Design. They consumed on two different days either 355 ml Red
Bull (RB) or 355 ml Placebo (Pla) in randomised order. The peripheral (PBP) and central blood
pressure (CBP) were measured before, during and after a 30-minute aerobic endurance training,
by the Schiller BR-102 plus PWA device.